The MOCOS gene xanthinuria type 2 genetic test is a specialized diagnostic procedure aimed at detecting mutations in the MOCOS gene, which are responsible for xanthinuria type 2, a rare metabolic disorder. This condition is characterized by an inability to properly metabolize purines, leading to an accumulation of xanthine in the body. Such accumulation can result in various health issues, including kidney stones and potentially leading to kidney failure if left untreated.
The test is performed by DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED, reflecting the sophisticated nature of the diagnostic process and the specialized expertise required to accurately interpret the results. This test is crucial for individuals suspected of having xanthinuria type 2 or for those with a family history of the condition, as early detection can significantly improve management and treatment outcomes.
The COL4A3 gene plays a crucial role in the development and function of the kidneys, ears, and eyes. Mutations in this gene are associated with Alport syndrome, a genetic disorder that affects the basement membranes of these organs, leading to progressive kidney disease, hearing loss, and eye abnormalities. The autosomal recessive form of Alport syndrome, which requires both parents to pass on a faulty copy of the COL4A3 gene, is one of the types of this condition.
To diagnose this form of Alport syndrome, a genetic test focusing on the COL4A3 gene is available. This test is crucial for confirming the diagnosis, understanding the inheritance pattern, and making informed decisions about family planning and management of the disease. The test analyzes the DNA to identify mutations in the COL4A3 gene that are known to cause the condition.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED. Conducting the test at DNA Labs UAE ensures that individuals and families affected by or at risk of Alport syndrome have access to accurate diagnosis and genetic counseling, which are essential for managing the condition effectively. This test is a valuable tool in the early detection and treatment planning for Alport syndrome, ultimately helping to improve the quality of life for those affected.
The COL4A4 gene plays a critical role in the formation of collagen IV, a major component of the basement membranes in various tissues, including the kidney, inner ear, and eye. Mutations in the COL4A4 gene can lead to Alport syndrome, a genetic disorder characterized by kidney disease, hearing loss, and eye abnormalities. Alport syndrome can be inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Genetic testing for mutations in the COL4A4 gene is crucial for the diagnosis and management of Alport syndrome. This test can confirm the diagnosis, guide treatment decisions, and help in assessing the risk of passing the condition on to future generations. DNA Labs UAE offers a comprehensive genetic test for the COL4A4 gene to identify mutations associated with Alport syndrome in an autosomal recessive inheritance pattern. The cost of the test is 4400 AED.
By conducting this test, healthcare providers and patients can gain valuable insights into the genetic basis of the condition, enabling personalized treatment plans and informed family planning decisions. DNA Labs UAE utilizes advanced genetic sequencing technologies to ensure accurate and reliable results, providing crucial information for the management of individuals with Alport syndrome and their families.
The COL4A5 gene Alport syndrome X-linked genetic test is a specialized diagnostic procedure aimed at identifying mutations in the COL4A5 gene, which is pivotal in diagnosing Alport syndrome. This condition is an inherited disorder that primarily affects the kidneys, leading to progressive loss of kidney function, and can also impact the ears and eyes. Since Alport syndrome is X-linked, it predominantly affects males, who are likely to experience more severe symptoms compared to females.
The test involves analyzing the patient's DNA to look for abnormalities in the COL4A5 gene, which is responsible for the production of a type of collagen essential for the normal functioning of the kidneys, ears, and eyes. Identifying mutations in this gene can confirm a diagnosis of Alport syndrome, enabling early intervention and management of the condition.
Conducted at DNA Labs UAE, the test cost is set at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals skilled in genetic testing, ensuring accurate and reliable results. Opting for this test at DNA Labs UAE provides patients and their families with critical information for managing Alport syndrome, including insights into the disease's progression, potential treatments, and the risk of passing the condition to future generations.
The DIAPH3 gene is associated with a form of auditory neuropathy, a condition characterized by a disruption in the transmission of sound from the inner ear to the brain, leading to hearing loss. This condition can be inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene is sufficient to cause the disorder. Genetic testing for mutations in the DIAPH3 gene can provide a definitive diagnosis of this form of auditory neuropathy, guiding treatment and management decisions for affected individuals and their families.
DNA Labs UAE offers a genetic test specifically targeting the DIAPH3 gene to identify mutations responsible for autosomal dominant auditory neuropathy. The test involves analyzing the patient's DNA, usually obtained through a blood sample, to search for abnormalities within the DIAPH3 gene that are known to cause the condition. This test is particularly useful for individuals showing symptoms of auditory neuropathy or those with a family history of the condition, as it can confirm the diagnosis and assist in understanding the risk of passing the condition to future generations.
The cost of the DIAPH3 gene auditory neuropathy autosomal dominant genetic test at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, the genetic analysis, and a comprehensive report of the findings. It's important for patients considering this test to consult with a healthcare provider or a genetic counselor to discuss the implications of the test results for themselves and their family members.
The PLCB4 Gene Auriculocondylar Syndrome Type 2 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the PLCB4 gene, which are linked to Auriculocondylar syndrome type 2 (ACS2). This condition is a rare genetic disorder characterized by craniofacial abnormalities, such as malformations of the ears and mandible (lower jaw). The test plays a crucial role in the accurate diagnosis and understanding of ACS2, facilitating targeted management and genetic counseling for affected families.
The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic variations in the PLCB4 gene that are associated with the syndrome. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed report provided by DNA Labs UAE. By offering this test, DNA Labs UAE supports healthcare professionals and families in identifying and addressing Auriculocondylar syndrome type 2, contributing to improved patient outcomes and quality of life.
The EYA1 Gene Branchiootorenal Syndrome Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the EYA1 gene, which are associated with Branchiootorenal (BOR) syndrome type 1. This syndrome is a rare genetic disorder characterized by the combination of branchial arch anomalies, hearing loss, and renal malformations. The test plays a crucial role in confirming the diagnosis, allowing for early intervention and management of the condition. Priced at 4400 AED, this test is a critical tool for families with a history of BOR syndrome, aiming to provide them with crucial information regarding their genetic status and the potential risks of passing the condition to their offspring. By leveraging advanced genetic testing techniques, DNA Labs UAE ensures accurate and reliable results, contributing to the effective care and counseling of affected individuals and their families.
The SLC52A3 gene plays a crucial role in the human body, as mutations in this gene are associated with Brown-Vialetto-Van Laere syndrome 1 (BVVLS1), a rare neurological disorder. This syndrome is characterized by a range of symptoms, including sensorineural hearing loss, cranial nerve palsies, and respiratory difficulties. Given the complexity and rarity of BVVLS1, genetic testing becomes a vital tool for accurate diagnosis and management of the condition.
DNA Labs UAE offers a specialized genetic test targeting the SLC52A3 gene to diagnose Brown-Vialetto-Van Laere syndrome 1. This test is crucial for individuals exhibiting symptoms of BVVLS1 or those with a family history of the disorder, providing them with a definitive diagnosis. The test involves analyzing the DNA to detect mutations in the SLC52A3 gene that are indicative of the syndrome.
The cost of the SLC52A3 gene test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to detect the specific genetic mutations associated with BVVLS1, offering patients and their families critical information for managing the condition. By identifying the genetic basis of the syndrome, healthcare providers can tailor treatment and support strategies to the individual needs of the patient, potentially improving their quality of life and outcomes.
The SLC52A2 gene plays a crucial role in the human body by facilitating the transport of riboflavin (vitamin B2) into cells, a vital process for cellular function and energy metabolism. Mutations in the SLC52A2 gene can lead to Brown-Vialetto-Van Laere syndrome type 2, a rare genetic disorder characterized by a range of neurological symptoms such as sensorineural hearing loss, muscle weakness, and respiratory difficulties.
To diagnose this condition, a specific genetic test targeting the SLC52A2 gene can be performed. This test involves analyzing the DNA to identify mutations in the SLC52A2 gene that are known to cause Brown-Vialetto-Van Laere syndrome type 2. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
In the UAE, this genetic test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the SLC52A2 gene test for Brown-Vialetto-Van Laere syndrome type 2 at DNA Labs UAE is 4400 AED. This test provides a valuable tool for families seeking answers to complex neurological symptoms, offering insights that can guide treatment and support strategies.
The IARS2 gene plays a critical role in human development and health, with mutations in this gene being associated with a rare but complex syndrome. This condition is characterized by a constellation of symptoms including cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia. These symptoms can significantly affect the quality of life, making early diagnosis and management crucial.
To aid in the diagnosis of this condition, DNA Labs UAE offers a genetic test specifically designed to analyze the IARS2 gene for mutations. This test is a valuable tool for clinicians and families seeking answers to unexplained symptoms related to the mentioned conditions. The genetic test can help in confirming the diagnosis, which is essential for the proper management and treatment of the affected individuals.
The cost of the IARS2 gene test at DNA Labs UAE is 4400 AED. This investment can provide critical information for the affected individuals and their families, guiding them towards appropriate interventions and potentially improving outcomes. It's important for patients considering this test to consult with a healthcare professional or a genetic counselor to understand the implications of the test results and to ensure it's the right step for their specific situation.
